Get startedLog in
    Picture of Basilea Pharmaceutica AG, Allschwil logo

    BSLN — Basilea Pharmaceutica AG, Allschwil News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Basilea Pharmaceutica Gets $13 Million From Barda For Ceftibuten-Ledaborbactam Development

    Picture of Basilea Pharmaceutica AG, Allschwil logoBasilea Pharmaceutica AG, Allschwil
    28/05/2026 06:16
    BRIEF-Basilea Pharmaceutica Gets $13 Million From Barda For Ceftibuten-Ledaborbactam Development
    May 28 (Reuters) - Basilea Pharmaceutica AG Allschwil BSLN.S:
    • BASILEA PHARMACEUTICA - BARDA AWARDS $13.3 MILLION TO BASILEA FOR CEFTIBUTEN-LEDABORBACTAM DEVELOPMENT
    • BASILEA PHARMACEUTICA - BARDA TOTAL COMMITMENT TO BASILEA REACHES $25 MILLION; CONTRACT UP TO $133 MILLION ADDITIONAL
    Source text: ID:nGNX6dN80V
    Further company coverage: BSLN.S

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Basilea Pharmaceutica AG, Allschwil

    See all news